E139 SGLT2 inhibitors for kidney and heart disease

Published: Sept. 19, 2022, 2 p.m.

b'

Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.

'